In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Illumina is an applied genomics technology company that was founded in 1998 with the mission statement: ‘To improve human health by unlocking the power of the genome’. Over the past two ...

Why has Illumina stock lost one third of its value in the 12 months from August 1, 2023 to August 1, 2024? Why are some scientists, such as those I have heard at genomics conferences, discussing ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

The call was made by the founder of Chair Centre Group, Ibukun Awosika, at the ISCAN’s 48th Annual Conference, held on Thursday in Lagos. She stated that the conference’s theme: “Reassessing ...

Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...

(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...

A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ:ILMN) 2021 acquisition of cancer test developer Grail (NASDAQ:GRAL), eliminating the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Europe’s top court dealt a blow to Brussels regulators on Tuesday after it agreed with US biotech ...

BENGALURU: Illumina, a global leader in DNA sequencing and array-based technologies, announced it will establish a Global CapabilityCenter in Bengaluru to expand its technology workforce in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...